|
Total participants
|
82 (100)
|
|
Suspected TB patients per week
|
|
0
|
28 (34)
|
|
1–2
|
47 (57)
|
|
3–5
|
7 (9)
|
|
Referral of suspected TB patients
|
|
Nearby laboratory
|
22 (27)
|
|
Nearby GP
|
19 (23)
|
|
Chest physician
|
65 (79)
|
|
TB DOTS centre
|
0 (0)
|
|
No referral
| |
|
Dispense broad spectrum antibiotics
|
11 (13)
|
|
Dispense cough syrup
|
28 (34)
|
|
Dispense anti-TB drugs
|
1 (1)
|
|
TB patients with a doctor’s prescription
|
82 (100)
|
|
Prescriped duration of anti-TB drugs
|
|
6 months
|
62 (76)
|
|
9 months
|
16 (19)
|
|
Do not know
|
4 (5)
|
|
Number of prescribed anti-TB drugs
|
|
2 medicines
|
25 (30)
|
|
3 medicines
|
39 (48)
|
|
4 medicines
|
18 (22)
|
|
Vitamin B6 supplement in prescription
|
73 (89)
|
|
Frequently sold TB medicines
|
|
4-FDC-RHZE combination
|
82 (100)
|
|
3-FDC-RHE combination
|
7 (8)
|
|
2-FDC-RH combination
|
79 (96)
|
|
Isoniazid
|
1 (1)
|
|
Pyrazinamide
|
0 (0)
|
|
Ethambutol
|
0 (0)
|
|
Streptomycin
|
28 (34)
|
|
Kanamycin
|
4 (5)
|
|
Patients buy anti-TB medicines
|
|
1 month
|
7 (8)
|
|
2 months
|
11 (13)
|
|
3 months
|
22 (27)
|
|
4 months
|
3 (4)
|
|
6 months
|
35 (43)
|
|
9 months
|
4 (5)
|
